Corvus Pharmaceuticals Inc (CRVS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Corvus Pharmaceuticals Inc-Aktie (CRVS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	3.41% 10.26	9.922	8.105	7.255	5.935
Depreciation and Amortization	31.82% 0.029	0.022	0.035	0.02	0.021
Operating Income/Loss	3.41% -10.26	-9.922	-8.105	-7.255	-5.935
Nonoperating Income/Loss	109.01% 2.262	-25.11	-	-	-
Income/Loss Before Equity Method Investments	148.37% -7.609	15.73	-9.939	-39.53	-3.685
Income/Loss From Equity Method Investments	27.83% -0.389	-0.539	-2.174	-0.682	-0.577
Income/Loss From Continuing Operations Before Tax	148.37% -7.609	15.73	-9.939	-39.53	-3.685
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	150.08% -7.609	15.19	-9.939	-39.53	-4.262
Net Income/Loss	152.64% -7.998	15.19	-12.11	-40.22	-4.262
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	7.83% 77.77	72.13	2.4719	66.70	59.71
Diluted Average Shares	3.49% 77.77	75.15	2.4719	66.70	59.71
Basic Earnings Per Share	147.62% -0.10	0.21	-0.16	-0.60	-0.07
Diluted Earnings Per Share	23.08% -0.10	-0.13	-0.16	-0.60	-0.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%